Back
Mesoblast Vs. Alterity Therapeutics Industry Stock Comparison
Buy
59
MESO
Mesoblast
Last Price:
11.32
Seasonality Move:
5.45%
Sell
31
ATHE
Alterity Therapeutics
Last Price:
1.17
Seasonality Move:
2.19%
Buy
59
Mesoblast (MESO)
is a Buy
Is Mesoblast a Buy, Sell or Hold?
- The current Mesoblast [MESO] share price is $11.70. The Score for MESO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- MESO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Alterity Therapeutics (ATHE)
is a Sell
Is Alterity Therapeutics a Buy, Sell or Hold?
- The current Alterity Therapeutics [ATHE] share price is $1.18. The Score for ATHE is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- ATHE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MESO Stock Price Chart
ATHE Stock Price Chart
What is Alterity Therapeutics's stock price today?
-
The Alterity Therapeutics share price today is $1.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATHE is experiencing selling pressure, which indicates risk of future bearish movement.
MESO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.41 | Buy |
| Relative Strength Index (14 RSI): | 74.41 | Buy |
| Chaikin Money Flow: | 340480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.57 - 9.99) | Buy |
| Bollinger Bands (100): | (6.23 - 8.91) | Buy |
ATHE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 46.33 | Sell |
| Chaikin Money Flow: | -8403 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.16 - 1.24) | Sell |
| Bollinger Bands (100): | (1.16 - 1.68) | Sell |
MESO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.38 | Buy |
| 20-day SMA: | 9.2 | Buy |
| 50-day SMA: | 8.3 | Buy |
| 200-day SMA: | 6.24 | Buy |
| 8-day EMA: | 9.77 | Buy |
| 20-day EMA: | 9.27 | Buy |
| 50-day EMA: | 8.57 | Buy |
| 200-day EMA: | 6.75 | Buy |
ATHE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.18 | Buy |
| 20-day SMA: | 1.18 | Buy |
| 50-day SMA: | 1.24 | Sell |
| 200-day SMA: | 1.69 | Sell |
| 8-day EMA: | 1.18 | Buy |
| 20-day EMA: | 1.19 | Sell |
| 50-day EMA: | 1.27 | Sell |
| 200-day EMA: | 1.69 | Sell |
Mesoblast Earnings Growth & MESO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alterity Therapeutics Earnings Growth & ATHE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.00 per share.
Mesoblast Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alterity Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||